‘ResAppDx-US has not been approved and that additional information is required to demonstrate that the probable benefits of the device outweigh its probable risks’
Just think about this for a second and imagine at this point in time how they could possibly have come to this conclusion, unless of course it was submitted by Experien on a couple of squares of toilet paper.
Is it really a surprise though from a country that brought us this guy?
https://youtu.be/FJuIT0ojx_k
If it wasn’t so frightening it would be funny!
- Forums
- ASX - By Stock
- RAP
- Telehealth on the rise
Telehealth on the rise, page-1810
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 1,265 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online